1. DSpace at My University
  2. E-Journal
  3. Farmasi
  4. Jurnal Internasional
  5. Journal of Taibah University Medical Sciences
  6. Vol 17 No 3 (2022)
Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/7269
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMungmunpuntipantip, Rujittika-
dc.contributor.authorWiwanitkit, Viroj-
dc.date.accessioned2024-11-05T04:19:56Z-
dc.date.available2024-11-05T04:19:56Z-
dc.date.issued2022-
dc.identifier.issn1658-3612-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/7269-
dc.description.abstractA second booster dose of COVID-19 vaccine is a widely discussed issue globally. This letter to the editor describes on possible additional immunoprotection due to the fourth dose of COVID-19 vaccine. According to the modeling study, it can demonstrate that the fourth dosage of COVID-19 vaccination can still provide extra immunoprotection in case that previous doses are not the highly effective COVID-19 vaccines.en_US
dc.language.isoen_USen_US
dc.publisherJournal of Taibah University Medical Sciencesen_US
dc.relation.ispartofseriesLetter to the Editor;533-536-
dc.subjectBooster doseen_US
dc.subjectCOVID-19en_US
dc.subjectFourthen_US
dc.subjectVaccineen_US
dc.titleFourth dose of COVID-19 vaccine: Does it still contribute any additional immunoprotection?en_US
dc.typeArticleen_US
Appears in Collections:Vol 17 No 3 (2022)

Files in This Item:
File Description SizeFormat 
533-536.pdf533-5361.2 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.